Toronto Dominion Bank
REGN icon

Toronto Dominion Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Toronto Dominion Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-31,500
Closed -$11.8M – 1412
2019
Q4 		$11.8M Buy
31,500
+14,500
+85% +$4.88M 0.02% 436
2019
Q3 		$4.72M Buy
17,000
+13,400
+372% +$3.97M 0.01% 658
2019
Q2 		$564K Buy
+3,600
New +$1.2M ﹤0.01% 1046

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Toronto Dominion Bank's REGN Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 29% in Q1 2026, selling an estimated $11.9M and leaving 38,427 shares worth $29.7M. The position accounts for 0.04% of the portfolio, ranked #328.

Toronto Dominion Bank first reported a position in REGN in Q4 2013 and has held it in 50 quarters since. The position peaked at $59.9M in Q1 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Toronto Dominion Bank held 38,427 shares of Regeneron Pharmaceuticals worth $29.7M as of Q1 2026.
  • Toronto Dominion Bank sold 15,531 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $11.9M.
  • Regeneron Pharmaceuticals made up 0.04% of Toronto Dominion Bank's portfolio in Q1 2026, its #328 holding.
  • Toronto Dominion Bank first reported a position in Regeneron Pharmaceuticals in Q4 2013 and has held it in 50 quarters since.
  • Toronto Dominion Bank's Regeneron Pharmaceuticals position peaked at $59.9M in Q1 2024.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.